{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:53:00Z","timestamp":1781632380307,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous studies have shown pharmacist-based interventions improve blood pressure (BP) control in individuals with hypertension. Here, we evaluated provider attitudes towards the utilization of at-home self-monitoring of BP, clinical pharmacist support, and pharmacist-guided medication self-titration in the management of hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a quality improvement project at the University of Iowa Hospitals and Clinics and the Iowa City VA Health Care System. We conducted an electronic survey to determine the attitudes of providers regarding various strategies in the management of hypertension. We surveyed primary care providers, internal medicine residents, nephrologists, cardiologists, nephrology and cardiology fellows, and nurse practitioners. Continuous data were summarized with medians and interquartile ranges and compared across strata using Wilcoxon rank sum tests. Categorical variables were summarized as counts and percentages and compared using Fisher\u2019s exact tests. Analyses were stratified by training status, specialty, and clinical setting. Open-ended comments were analyzed for overarching themes and positive, negative, or neutral sentiment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 413 surveyed providers, 153 completed the survey, the majority of whom (78%) identified their role as clinicians. We observed high confidence in the diagnosis and treatment of hypertension among all surveyed groups. 91% of providers (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009132) reported that at least once per week or more frequently, their decision to up-titrate BP medications was influenced by a patient\u2019s home BP readings. Nearly half of those surveyed indicated that they had never referred their patients to a clinical pharmacist for BP medication management and a third reported doing so rarely (once or twice a month or less). Respondents, however, agreed that clinical pharmacists could support clinical decision-making for managing BP medications (68%), reduce the burden on providers (68%), and improve the safety of HTN treatment plans (72%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Clinical pharmacists are underutilized in clinical practice although providers expressed favorable perception of clinical pharmacists\u2019 roles in the management of hypertension. Considering the evidence that pharmacist-based management of high BP improves BP control, interventions are needed to improve pharmacist utilization in the maagement of hypertension.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-025-04731-x","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:36:03Z","timestamp":1769243763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Provider perspectives on self-management of hypertension: a survey of perceptions and clinical pharmacist utilization"],"prefix":"10.1186","volume":"27","author":[{"given":"Cole","family":"Howie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Al-Masry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Van Eyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linder","family":"Wendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Geasland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korey","family":"Kennelty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"4731_CR1","doi-asserted-by":"publisher","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American heart Association Task Force on clinical practice guidelines. Circulation. 2017. 2018;138(17):e484\u2013594. https:\/\/doi.org\/10.1161\/CIR.0000000000000596.","DOI":"10.1161\/CIR.0000000000000596"},{"issue":"9859","key":"4731_CR2","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","volume":"380","author":"SS Lim","year":"2012","unstructured":"Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010. A systematic analysis for the global burden of disease study 2010. Lancet Lond Engl. 2012;380(9859):2224\u201360. https:\/\/doi.org\/10.1016\/S0140-6736(12)61766-8.","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"4731_CR3","doi-asserted-by":"publisher","first-page":"e1000058","DOI":"10.1371\/journal.pmed.1000058","volume":"6","author":"G Danaei","year":"2009","unstructured":"Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6(4):e1000058. https:\/\/doi.org\/10.1371\/journal.pmed.1000058.","journal-title":"PLoS Med"},{"issue":"16","key":"4731_CR4","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1161\/CIRCULATIONAHA.110.005645","volume":"123","author":"ES Ford","year":"2011","unstructured":"Ford ES. Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation. 2011;123(16):1737\u201344. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.005645.","journal-title":"Circulation"},{"key":"4731_CR5","doi-asserted-by":"publisher","unstructured":"Muntner P, Miles MA, Jaeger BC, et al. Blood pressure control among us adults & comma; 2009 to 2012 through 2017 to 2020. Hypertens Dallas Tex 1979. 2022;79(9):1971\u201380. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.19222.","DOI":"10.1161\/HYPERTENSIONAHA.122.19222"},{"issue":"20","key":"4731_CR6","doi-asserted-by":"publisher","first-page":"e034568","DOI":"10.1161\/JAHA.124.034568","volume":"13","author":"S Akbari","year":"2024","unstructured":"Akbari S, Ten Eyck P, Wendt L, et al. Trends of blood pressure control in chronic kidney disease among us adults: findings from NHANES & comma; 2011 to 2020. J Am Heart Assoc. 2024;13(20):e034568. https:\/\/doi.org\/10.1161\/JAHA.124.034568.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"4731_CR7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/HJH.0000000000003424","volume":"41","author":"M Yamada","year":"2023","unstructured":"Yamada M, Wachsmuth J, Sambharia M, et al. The prevalence and treatment of hypertension in Veterans Health Administration, assessing the impact of the updated clinical guidelines. J Hypertens. 2023;41(6):995\u20131002. https:\/\/doi.org\/10.1097\/HJH.0000000000003424.","journal-title":"J Hypertens"},{"key":"4731_CR8","doi-asserted-by":"publisher","unstructured":"Members WC, Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, et al. AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American heart Association joint Committee on clinical practice guidelines. Hypertension. 2025. 2025, Oct;82(10):e212\u2013316. https:\/\/doi.org\/10.1161\/HYP.0000000000000249. Epub 2025 Aug 14. PMID: 40811516.","DOI":"10.1161\/HYP.0000000000000249"},{"key":"4731_CR9","doi-asserted-by":"publisher","unstructured":"Ogedegbe G, Schoenthaler A. A systematic review of the effects of home blood pressure monitoring on medication adherence. J Clin Hypertens Greenwich Conn. 2006;8(3):174\u201380. https:\/\/doi.org\/10.1111\/j.1524-6175.2006.04872.x.","DOI":"10.1111\/j.1524-6175.2006.04872.x"},{"issue":"5","key":"4731_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3109\/07853890.2010.489567","volume":"42","author":"EP Bray","year":"2010","unstructured":"Bray EP, Holder R, Mant J, McManus RJ. Does self-monitoring reduce blood pressure? meta-analysis with meta-regression of randomized controlled trials. Ann Med. 2010;42(5):371\u201386. https:\/\/doi.org\/10.3109\/07853890.2010.489567.","journal-title":"Ann Med"},{"issue":"4","key":"4731_CR11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/jch.14795","volume":"26","author":"NP Carey","year":"2024","unstructured":"Carey NP, Curtis F, Eisenbeisz ML, et al. Does home blood pressure monitoring improve blood pressure-related outcomes in people living with chronic kidney disease? A systematic review. J Clin Hypertens Greenwich Conn. 2024;26(4):314\u201329. https:\/\/doi.org\/10.1111\/jch.14795.","journal-title":"J Clin Hypertens Greenwich Conn"},{"key":"4731_CR12","doi-asserted-by":"publisher","unstructured":"Sheppard JP, Tucker KL, Davison WJ, et al. Self-monitoring of blood pressure in patients with hypertension-related multi-morbidity: systematic review and individual patient data meta-analysis. Am J Hypertens. 2020;33(3):243\u201351. https:\/\/doi.org\/10.1093\/ajh\/hpz182.","DOI":"10.1093\/ajh\/hpz182"},{"issue":"8","key":"4731_CR13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/jama.2014.10057","volume":"312","author":"RJ McManus","year":"2014","unstructured":"McManus RJ, Mant J, Haque MS, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. Jama. 2014;312(8):799\u2013808. https:\/\/doi.org\/10.1001\/jama.2014.10057.","journal-title":"Jama"},{"issue":"1","key":"4731_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40814-019-0410-0","volume":"5","author":"C Hopley","year":"2019","unstructured":"Hopley C, Andrews E, Klem P, et al. Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD. Pilot Feasibility Stud. 2019;5(1):23. https:\/\/doi.org\/10.1186\/s40814-019-0410-0.","journal-title":"Pilot Feasibility Stud"},{"key":"4731_CR15","doi-asserted-by":"publisher","unstructured":"Omboni S, Caserini M. Effectiveness of pharmacist\u2019s intervention in the management of cardiovascular diseases. Open Heart. 2018;5(1). https:\/\/doi.org\/10.1136\/openhrt-2017-000687.","DOI":"10.1136\/openhrt-2017-000687"},{"key":"4731_CR16","doi-asserted-by":"publisher","unstructured":"Machado M, Nassor N, Bajcar JM, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part iii: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother. 2008;42(9). https:\/\/doi.org\/10.1345\/aph.1K618.","DOI":"10.1345\/aph.1K618"},{"key":"4731_CR17","doi-asserted-by":"publisher","unstructured":"Charrois TL, Zolezzi M, Koshman SL, et al. A systematic review of the evidence for pharmacist care of patients with dyslipidemia. Pharmacotherapy. 2012;32(3). https:\/\/doi.org\/10.1002\/j.1875-9114.2012.01022.x.","DOI":"10.1002\/j.1875-9114.2012.01022.x"},{"key":"4731_CR18","doi-asserted-by":"publisher","unstructured":"Ponniah A, Anderson B, Shakib S, Doecke CJ, Angley M. Pharmacists\u2019 role in the post-discharge management of patients with heart failure: a literature review. J Clin Pharm Ther. 2007;32(4). https:\/\/doi.org\/10.1111\/j.1365-2710.2007.00827.x.","DOI":"10.1111\/j.1365-2710.2007.00827.x"},{"key":"4731_CR19","doi-asserted-by":"publisher","unstructured":"Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008;168(7). https:\/\/doi.org\/10.1001\/archinte.168.7.687.","DOI":"10.1001\/archinte.168.7.687"},{"key":"4731_CR20","doi-asserted-by":"publisher","unstructured":"Cheng JWM, Cooke-Ariel H. Pharmacists\u2019 role in the care of patients with heart failure: review and future evolution. J Manag Care Pharm. 2014;20(2). https:\/\/doi.org\/10.18553\/jmcp.2014.20.2.206.","DOI":"10.18553\/jmcp.2014.20.2.206"},{"key":"4731_CR21","doi-asserted-by":"publisher","unstructured":"Carter BL, Coffey CS, Ardery G, et al. Cluster-randomized trial of a physician\/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015;8(3). https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.114.001283.","DOI":"10.1161\/CIRCOUTCOMES.114.001283"},{"key":"4731_CR22","doi-asserted-by":"publisher","unstructured":"Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008;23(12). https:\/\/doi.org\/10.1007\/s11606-008-0791-x.","DOI":"10.1007\/s11606-008-0791-x"},{"key":"4731_CR23","doi-asserted-by":"publisher","unstructured":"Hirsch JD, Steers N, Adler DS, et al. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clin Ther. 2014;36(9). https:\/\/doi.org\/10.1016\/j.clinthera.2014.06.030.","DOI":"10.1016\/j.clinthera.2014.06.030"},{"key":"4731_CR24","doi-asserted-by":"publisher","unstructured":"Wagner TD, Jones MC, Salgado TM, Dixon DL. Pharmacist\u2019s role in hypertension management: a review of key randomized controlled trials. J Hum Hypertens. 2020;34(7). https:\/\/doi.org\/10.1038\/s41371-020-0331-7.","DOI":"10.1038\/s41371-020-0331-7"},{"issue":"5","key":"4731_CR25","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3390\/jcm13051367","volume":"13","author":"JJ Neumiller","year":"2024","unstructured":"Neumiller JJ, St Peter WL, Shubrook JH. Type 2 diabetes and chronic kidney disease: an opportunity for pharmacists to improve outcomes. J Clin Med. 2024;13(5):1367. https:\/\/doi.org\/10.3390\/jcm13051367.","journal-title":"J Clin Med"},{"key":"4731_CR26","doi-asserted-by":"publisher","unstructured":"Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy. 2001;21(11). https:\/\/doi.org\/10.1592\/phco.21.17.1337.34424.","DOI":"10.1592\/phco.21.17.1337.34424"},{"key":"4731_CR27","doi-asserted-by":"publisher","unstructured":"Parker CP, Cunningham CL, Carter BL, Vander Weg MW, Richardson KK, Rosenthal GE. A mixed-method approach to evaluate a pharmacist intervention for Veterans with hypertension. J Clin Hypertens. 2014;16(2). https:\/\/doi.org\/10.1111\/jch.12250.","DOI":"10.1111\/jch.12250"},{"key":"4731_CR28","doi-asserted-by":"publisher","unstructured":"Vordenberg SE, Thompson AN, Vereecke A, et al. Primary care provider perceptions of an integrated community pharmacy hypertension management program. J Am Pharm Assoc. 2021;61(3). https:\/\/doi.org\/10.1016\/j.japh.2020.11.022.","DOI":"10.1016\/j.japh.2020.11.022"},{"key":"4731_CR29","doi-asserted-by":"publisher","unstructured":"Polgreen LA, Han J, Carter BL, et al. Cost-effectiveness of a physician-pharmacist collaboration intervention to improve blood pressure control. Hypertension. 2015;66(6). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06023.","DOI":"10.1161\/HYPERTENSIONAHA.115.06023"},{"key":"4731_CR30","doi-asserted-by":"publisher","unstructured":"Bryant KB, Moran AE, Kazi DS, et al. Cost-effectiveness of hypertension treatment by pharmacists in black barbershops. Circulation. 2021;143(24). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.051683.","DOI":"10.1161\/CIRCULATIONAHA.120.051683"},{"key":"4731_CR31","doi-asserted-by":"publisher","unstructured":"Trejo L, Carson P, Wilkins N. Pharmacist-led hypertension management in a minority patient population. J Am Pharm Assoc. 2024;64(2). https:\/\/doi.org\/10.1016\/j.japh.2023.11.019.","DOI":"10.1016\/j.japh.2023.11.019"},{"key":"4731_CR32","doi-asserted-by":"publisher","unstructured":"Sisson EM, Dixon DL, Kildow DC, et al. Effectiveness of a pharmacist-physician team-based collaboration to improve long-term blood pressure control at an inner-city safety-net clinic. Pharmacotherapy. 2016;36(3). https:\/\/doi.org\/10.1002\/phar.1710.","DOI":"10.1002\/phar.1710"},{"issue":"6","key":"4731_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/HCO.0000000000000674","volume":"34","author":"CA Blyler","year":"2019","unstructured":"Blyler CA, Rader F. Sustainability of blood pressure reduction in black barbershops. Curr Opin Cardiol. 2019;34(6):693\u201399. https:\/\/doi.org\/10.1097\/HCO.0000000000000674.","journal-title":"Curr Opin Cardiol"},{"issue":"6","key":"4731_CR34","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1053\/j.ajkd.2005.02.027","volume":"45","author":"MS Joy","year":"2005","unstructured":"Joy MS, DeHart RM, Gilmartin C, et al. Clinical pharmacists as multidisciplinary health care providers in the management of CKD: a joint opinion by the nephrology and Ambulatory care practice and research networks of the American College of clinical pharmacy. Am J Kidney Dis Off J Natl Kidney Found. 2005;45(6):1105\u201318. https:\/\/doi.org\/10.1053\/j.ajkd.2005.02.027.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"4731_CR35","doi-asserted-by":"publisher","unstructured":"Leal S, Soto M. Chronic kidney disease risk reduction in a hispanic population through pharmacist-based disease-state management. Adv Chronic Kidney Dis. 2008;15(2). https:\/\/doi.org\/10.1053\/j.ackd.2008.01.007.","DOI":"10.1053\/j.ackd.2008.01.007"},{"issue":"1","key":"4731_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1345\/aph.1E269","volume":"39","author":"HR Patel","year":"2005","unstructured":"Patel HR, Pruchnicki MC, Hall LE. Assessment for chronic kidney disease service in high-risk patients at community health clinics. Ann Pharmacother. 2005;39(1):22\u201327. https:\/\/doi.org\/10.1345\/aph.1E269.","journal-title":"Ann Pharmacother"},{"key":"4731_CR37","doi-asserted-by":"publisher","unstructured":"Vu A, Nicholas SB, Waterman AD, et al. \u201cPositive kidney Health\u201d: implementation and design of a pharmacist-led intervention for patients at risk for development or progression of chronic kidney disease. J Am Pharm Assoc. 2023;63(2). https:\/\/doi.org\/10.1016\/j.japh.2022.11.007.","DOI":"10.1016\/j.japh.2022.11.007"},{"key":"4731_CR38","doi-asserted-by":"publisher","unstructured":"Wl SP, Farley TM, Carter BL. Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patients. Curr Opin Nephrol Hypertens. 2011;20(5). https:\/\/doi.org\/10.1097\/MNH.0b013e32834902c8.","DOI":"10.1097\/MNH.0b013e32834902c8"},{"key":"4731_CR39","doi-asserted-by":"publisher","unstructured":"Nakanishi M, Mizuno T, Mizokami F, et al. Impact of pharmacist intervention for blood pressure control in patients with chronic kidney disease: a meta-analysis of randomized clinical trials. J Clin Pharm Ther. 2021;46(1). https:\/\/doi.org\/10.1111\/jcpt.13262.","DOI":"10.1111\/jcpt.13262"},{"issue":"1","key":"4731_CR40","doi-asserted-by":"publisher","first-page":"e015332","DOI":"10.1136\/bmjopen-2016-015332","volume":"8","author":"K Kvarnstr\u00f6m","year":"2018","unstructured":"Kvarnstr\u00f6m K, Airaksinen M, Liira H. Barriers and facilitators to medication adherence: a qualitative study with general practitioners. BMJ Open. 2018;8(1):e015332. https:\/\/doi.org\/10.1136\/bmjopen-2016-015332.","journal-title":"BMJ Open"},{"issue":"12","key":"4731_CR41","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/ajhp\/zxad045","volume":"80","author":"S Gadd","year":"2023","unstructured":"Gadd S, Cox N, Slager S, Pinnock E, Mitchell M, Turner K. Assessing the impact of a payor-funded embedded clinical pharmacist on patient and provider satisfaction in a private primary care practice. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm. 2023;80(12):742\u201349. https:\/\/doi.org\/10.1093\/ajhp\/zxad045.","journal-title":"Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm"},{"key":"4731_CR42","doi-asserted-by":"publisher","unstructured":"Ray S, Lokken J, Whyte C, Baumann A, Oldani M. The impact of a pharmacist-driven, collaborative practice on diabetes management in an Urban underserved population: a mixed method assessment. J Interprof Care. 2020;34(1). https:\/\/doi.org\/10.1080\/13561820.2019.1633289.","DOI":"10.1080\/13561820.2019.1633289"},{"issue":"6","key":"4731_CR43","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.japh.2017.06.018","volume":"57","author":"G Moreno","year":"2017","unstructured":"Moreno G, Lonowski S, Fu J, et al. Physician experiences with clinical pharmacists in primary care teams. J Am Pharm Assoc JAPhA. 2017;57(6):686\u201391. https:\/\/doi.org\/10.1016\/j.japh.2017.06.018.","journal-title":"J Am Pharm Assoc JAPhA"},{"issue":"9736","key":"4731_CR44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0140-6736(10)60964-6","volume":"376","author":"RJ McManus","year":"2010","unstructured":"McManus RJ, Mant J, Bray EP, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet Lond Engl. 2010;376(9736):163\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(10)60964-6.","journal-title":"Lancet Lond Engl"},{"key":"4731_CR45","doi-asserted-by":"publisher","first-page":"107950","DOI":"10.1016\/j.cct.2025.107950","volume":"154","author":"M Good","year":"2025","unstructured":"Good M, Hoskins R, Lund BC, et al. A clinical trial evaluating pharmacist-guided self-management of hypertension among veterans with CKD, rationale and study design. Contemp Clin Trials. 2025;154:107950. https:\/\/doi.org\/10.1016\/j.cct.2025.107950.","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"4731_CR46","doi-asserted-by":"publisher","first-page":"e057191","DOI":"10.1136\/bmjopen-2021-057191","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, Liang X, Wang Y, et al. Barriers to and facilitators of the implementation of pharmacist services in primary care clinics: a scoping review protocol. BMJ Open. 2022, Jan, 11;12(1):e057191. https:\/\/doi.org\/10.1136\/bmjopen-2021-057191.","journal-title":"BMJ Open"},{"issue":"13","key":"4731_CR47","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.jacc.2009.08.001","volume":"54","author":"GP Rodgers","year":"2009","unstructured":"Rodgers GP, Conti JB, Feinstein JA, et al. Acc, 2009 survey results and recommendations: addressing the Cardiology Workforce crisis: a report of the acc Board of trustees Workforce Task Force. J Am Coll Cardiol. 2009;54(13):1195\u2013208. https:\/\/doi.org\/10.1016\/j.jacc.2009.08.001.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"4731_CR48","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.sapharm.2020.10.002","volume":"17","author":"IP Ulrich","year":"2021","unstructured":"Ulrich IP, Lugo B, Hughes P, et al. Access to clinical pharmacy services in a pharmacist-physician covisit model. Res Soc Adm Pharm RSAP. 2021;17(7):1321\u201326. https:\/\/doi.org\/10.1016\/j.sapharm.2020.10.002.","journal-title":"Res Soc Adm Pharm RSAP"},{"key":"4731_CR49","doi-asserted-by":"publisher","unstructured":"Geese F, Schmitt KU. Interprofessional collaboration in complex patient care transition: a qualitative multi-perspective analysis. Healthc Basel Switz. 2023;11(3):359. https:\/\/doi.org\/10.3390\/healthcare11030359.","DOI":"10.3390\/healthcare11030359"},{"key":"4731_CR50","unstructured":"Buckley P, Grime J, Blenkinsopp A. Inter- and intra-professional perspectives on non-medical prescribing in an NHS trust. The pharmaceutical journal. 2009 June 19. https:\/\/pharmaceutical-journal.com\/article\/research\/inter-and-intra-professional-perspectives-on-non-medical-prescribing-in-an-nhs-trust. Accessed June 9, 2025."},{"key":"4731_CR51","unstructured":"Veterans Affairs. VA.Gov | Veterans Affairs. https:\/\/www.patientcare.va.gov\/primarycare\/PACT.asp. Accessed May 11, 2025."},{"issue":"2","key":"4731_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1258\/hsmr.2012.012001","volume":"25","author":"JA Alexander","year":"2012","unstructured":"Alexander JA, Bae D. Does the patient-centred medical home work? A critical synthesis of research on patient-centred medical homes and patient-related outcomes. Health Serv Manage Res. 2012;25(2):51\u201359. https:\/\/doi.org\/10.1258\/hsmr.2012.012001.","journal-title":"Health Serv Manage Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04731-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04731-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04731-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:04:38Z","timestamp":1781629478000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04731-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4731"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04731-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a quality improvement project at the University of Iowa Hospitals and Clinics and the Iowa City VA Health Care System. The study was submitted for approval to the University of Iowa Institutional Review Board (UIIRB) with a declaration of intent to publish. The UIIRB determined the project was exempt from review and the need for informed consent was waived by the UIIRB under the Code of Federal Regulations (CFR) Title 45 Part 46.104, Office for Human Research Protections (OHRP). Participation in the survey was voluntary, and survey results were completely anonymous, with no identifying information collected. This research adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, as the manuscript does not contain any identifying images or individual data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}